CDLX — Cardlytics Cashflow Statement
0.000.00%
Last trade - 00:00- $60.54m
- $231.22m
- $278.30m
- 45
- 61
- 45
- 50
Annual cashflow statement for Cardlytics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -55.4 | -129 | -465 | -135 | -189 |
| Depreciation | |||||
| Non-Cash Items | 43.8 | 66.9 | 385 | 122 | 171 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -3.75 | -6.7 | -11.3 | -13.5 | -15.8 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Cash from Operating Activities | -7.6 | -38.5 | -53.9 | -0.185 | -8.82 |
| Capital Expenditures | -10.1 | -12.6 | -13.5 | -12.4 | -19.3 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | — | -494 | -2.27 | 2.33 | 0.552 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Cash from Investing Activities | -10.1 | -507 | -15.8 | -10.1 | -18.7 |
| Financing Cash Flow Items | -26.8 | -0.39 | -0.331 | -50 | -20.4 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 206 | 486 | -40 | -20 | 1.44 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 189 | -59.8 | -112 | -30.2 | -26.2 |